Lv21
130 积分 2024-07-10 加入
QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
2个月前
已完结
Comparative Analytical Evaluation of the Proposed Biosimilar FYB206 and its Reference Medicinal Product Keytruda®
2个月前
已完结
A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development
3个月前
已完结
Closed System Transfer Devices (CSTDs): Understanding Potential Over- and Under- Dosing of Liquid Vial Drug Products and How to Generally Mitigate
3个月前
已完结
[Antibody druggability screening process and evaluation strategy]
5个月前
已完结
皖公网安备34019202002308
